In a regulatory filing, the company states: "Recursion Pharmaceuticals confirms that it does not hold any deposits or securities or maintain any accounts at Silicon Valley Bank. We are currently evaluating counterparty risk and have discovered no material risk at this time."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RXRX: